Coarctation of the aorta in an infant exposed to etanercept in utero.
Hemmati
Iman
I
Stephanie
Ensworth
E
Shojania
Kam
K
D000328:Adult; D000818:Animals; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001011:Aorta / Q000002:abnormalities / Q000187:drug effects*; D001017:Aortic Coarctation / Q000139:chemically induced*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068800:Etanercept; D017809:Fatal Outcome; D005260:Female; D005333:Fetus / Q000002:abnormalities / Q000187:drug effects; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept